Medical Teacher,
Год журнала:
2024,
Номер
unknown, С. 1 - 14
Опубликована: Окт. 31, 2024
Background
With
the
advancement
of
Artificial
Intelligence
(AI),
it
has
had
a
profound
impact
on
medical
education.
Understanding
advantages
and
issues
AI
in
education,
providing
guidance
for
educators,
overcoming
challenges
implementation
process
is
particularly
important.
Journal of Global Health,
Год журнала:
2025,
Номер
15
Опубликована: Янв. 10, 2025
The
emergence
of
artificial
intelligence
(AI)
in
drug
discovery
represents
a
transformative
development
addressing
neglected
diseases,
particularly
the
context
developing
world.
Neglected
often
overlooked
by
traditional
pharmaceutical
research
due
to
limited
commercial
profitability,
pose
significant
public
health
challenges
low-
and
middle-income
countries.
AI-powered
offers
promising
solution
accelerating
identification
potential
candidates,
optimising
process,
reducing
time
cost
associated
with
bringing
new
treatments
market.
However,
while
AI
shows
promise,
many
its
applications
are
still
their
early
stages
require
human
validation
ensure
accuracy
reliability
predictions.
Additionally,
models
availability
high-quality
data,
which
is
sparse
regions
where
diseases
most
prevalent.
This
viewpoint
explores
application
for
examining
current
impact,
related
ethical
considerations,
broader
implications
It
also
highlights
opportunities
presented
this
context,
emphasising
need
ongoing
research,
oversight,
collaboration
between
stakeholders
fully
realise
transforming
global
outcomes.
PLOS Digital Health,
Год журнала:
2025,
Номер
4(2), С. e0000726 - e0000726
Опубликована: Фев. 24, 2025
The
safety
of
Artificial
Intelligence
(AI)
systems
is
as
much
one
human
decision-making
a
technological
question.
In
AI-driven
decision
support
systems,
particularly
in
high-stakes
settings
such
healthcare,
ensuring
the
human-AI
interactions
paramount,
given
potential
risks
following
erroneous
AI
recommendations.
To
explore
this
question,
we
ran
safety-focused
clinician-AI
interaction
study
physical
simulation
suite.
Physicians
were
placed
simulated
intensive
care
ward,
with
nurse
(played
by
an
experimenter),
ICU
data
chart,
high-fidelity
patient
mannequin
and
recommender
system
on
display.
Clinicians
asked
to
prescribe
two
drugs
for
patients
suffering
from
sepsis
wore
eye-tracking
glasses
allow
us
assess
where
their
gaze
was
directed.
We
recorded
clinician
treatment
plans
before
after
they
saw
recommendations,
which
could
be
either
‘safe’
or
‘unsafe’.
92%
clinicians
rejected
unsafe
recommendations
vs
29%
safe
ones.
paid
increased
attention
(+37%
fixations)
However,
visual
explanations
not
greater
scenarios.
Similarly,
clinical
information
(patient
monitor,
chart)
did
receive
more
versus
reveal
suggesting
that
physicians
look
back
these
sources
investigate
why
suggestion
might
unsafe.
only
successfully
persuaded
change
dose
scripted
comments
bedside
5%
time.
Our
emphasises
importance
oversight
safety-critical
value
evaluating
closely
resemble
real
world
practice.
Advances in computational intelligence and robotics book series,
Год журнала:
2025,
Номер
unknown, С. 319 - 338
Опубликована: Март 21, 2025
This
study
examines
the
application
of
human-cantered
artificial
intelligence
(AI)
in
Islamic
finance,
with
aim
bridging
modern
technology
and
tradition
to
improve
entrepreneurial
interaction.
In
era
digital
transformation,
AI
is
a
major
force
that
transforming
various
industries
including
financial
sector.
which
prioritizes
ethical
practices
social
justice,
has
unique
approach
integrating
according
sharia
principles.
research
aims
fill
literature
gap
regarding
finance
still
limited.
Through
in-depth
analysis
comprehensive
approach,
offers
practical
theoretical
guidance
for
institutions
operational
efficiency,
service
personalization,
productive
interactions.
Journal of Medical Ethics,
Год журнала:
2025,
Номер
unknown, С. jme - 110750
Опубликована: Март 27, 2025
Fervent
attention
was
paid
to
what
is
coined
dual-use
research
(DUR),
or
that
can
both
benefit
and
harm
humanity,
of
concern
(DURC),
a
particular
subset
DUR
reasonably
anticipated
be
safety
security
if
misapplied.
The
aim
this
paper
not
reiterate
the
challenges
DURC
governance
but
look
at
new
turn
in
DURC,
namely
posed
by
use
artificial
intelligence
(AI)
pharmaceutical
development.
This
important,
as
AI
increasingly
being
used
for
development
industry.
There
growing
recognition
there
dearth
industry
governmental
guidance.
Artificial Intelligence Surgery,
Год журнала:
2025,
Номер
5(2), С. 161 - 72
Опубликована: Апрель 2, 2025
Artificial
intelligence
(AI),
machine
learning
(ML),
and
image
guidance
are
increasingly
being
used
to
support
surgeons
in
preoperative,
intraoperative,
postoperative
decision
making
optimized
patient
care.
Surgery
is
the
cornerstone
of
curative
treatment
pancreatic
diseases,
a
large
amount
perioperative
data
becoming
available
with
widespread
application
minimally
invasive
surgical
techniques.
AI
showing
promise
prediction
malignancy
resectability
from
preoperative
images.
A
further
clinical
focus
complications,
especially
fistula,
several
algorithms
now
outperform
conventional
fistula
risk
scores.
Future
research
will
be
directed
toward
refinement
intraoperative
systems,
individualization
training,
improvement
pre-
oncologic
stratification
personalize
sequence
surgery
chemotherapy.
This
review
summarizes
recent
developments
for
surgery.
Integrated Pharmacy Research and Practice,
Год журнала:
2024,
Номер
Volume 13, С. 139 - 153
Опубликована: Авг. 1, 2024
The
field
of
healthcare
is
experiencing
a
significant
transformation
driven
by
technological
advancements,
scientific
breakthroughs,
and
focus
on
personalized
patient
care.
At
the
forefront
this
evolution
artificial
intelligence-driven
pharmacy
practice
(IDPP),
which
integrates
data
science
technology
to
enhance
pharmacists'
capabilities.
This
prospective
article
introduces
concept
"pharmacointelligence",
paradigm
shift
that
synergizes
intelligence
(AI),
integration,
clinical
decision
support
systems
(CDSS),
informatics
optimize
medication-related
processes.
Through
comprehensive
literature
review
analysis,
research
highlights
potential
pharmacointelligence
revolutionize
addressing
complexity
pharmaceutical
data,
changing
demands,
advancements.
identifies
critical
need
for
integrating
these
technologies
medication
management,
improve
outcomes,
streamline
operations.
It
also
underscores
importance
regulatory
ethical
considerations
in
implementing
pharmacointelligence,
ensuring
privacy,
security,
equitable
delivery.
The Ewha Medical Journal,
Год журнала:
2024,
Номер
47(4)
Опубликована: Сен. 12, 2024
Artificial
intelligence
(AI)
is
rapidly
transforming
various
medical
fields,
including
radiation
oncology.
This
review
explores
the
integration
of
AI
into
oncology,
highlighting
both
challenges
and
opportunities.
can
improve
precision,
efficiency,
outcomes
therapy
by
optimizing
treatment
planning,
enhancing
image
analysis,
facilitating
adaptive
therapy,
enabling
predictive
analytics.
Through
analysis
large
datasets
to
identify
optimal
parameters,
automate
complex
tasks,
reduce
planning
time,
accuracy.
In
AI-driven
techniques
enhance
tumor
detection
segmentation
processing
data
from
CT,
MRI,
PET
scans
enable
precise
delineation.
beneficial
because
it
allows
real-time
adjustments
plans
based
on
changes
in
patient
anatomy
size,
thereby
improving
accuracy
effectiveness.
Predictive
analytics
using
historical
predict
potential
complications,
guiding
clinical
decision-making
more
personalized
strategies.
Challenges
adoption
oncology
include
ensuring
quality
quantity,
achieving
interoperability
standardization,
addressing
regulatory
ethical
considerations,
overcoming
resistance
implementation.
Collaboration
among
researchers,
clinicians,
scientists,
industry
stakeholders
crucial
these
obstacles.
By
challenges,
drive
advancements
care
operational
efficiencies.
presents
an
overview
current
state
insights
future
directions
for
research
practice.